Literature DB >> 3006836

Modulation of neutrophil oxidative responses to soluble stimuli by platelet-activating factor.

J C Gay, J K Beckman, K A Zaboy, J N Lukens.   

Abstract

The role of platelet activating factor (PAF) as a regulator of human neutrophil superoxide (O2-) generation in response to soluble and particulate stimuli was examined. At concentrations greater than 10(-7) mol/L, PAF alone induced a brief burst of O2- production. When cells were exposed to PAF and either the chemotactic peptide n-formyl-methionyl-leucyl-phenylalanine (FMLP 10(-7) mol/L) or the tumor promoter phorbol myristate acetate (PMA 10 ng/mL), a marked synergistic augmentation of O2- release was noted when compared to control cells stimulated with FMLP or PMA alone. Mean percentage of enhancement by 10(-5) mol/L of PAF was 297% +/- 35% (n = 9) of control responses to FMLP and 185% +/- 16% (n = 3) of control responses to PMA. Consistent enhancement occurred with PAF concentrations of as low as 10(-9) mol/L. Enhancement could be demonstrated when neutrophils were exposed to PAF either at the same time as, or up to 60 minutes prior to, the second stimulus, and was neither reversed by removal of PAF from the medium prior to addition of FMLP or PMA nor dependent on the presence of extracellular divalent cations. Continuous recordings revealed that the enhancement was due to an increased maximal rate of O2- production. In contrast, PAF concentrations up to 10(-5) mol/L had only a minimal effect on the response to neutrophils to opsonized zymosan. Analysis of the enhancing properties of lipids structurally related to PAF revealed that the critical moiety was the saturated fatty acid at position 1. These results indicate the presence of a PAF-mediated positive feedback loop whereby the oxidative burst induced by some soluble stimuli is augmented. Modulation of neutrophil O2- production by PAF may serve to amplify neutrophil oxidative responses at sites of inflammation.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3006836

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  20 in total

1.  Activation of the Raf-MEK-ERK pathway is required for neutrophil extracellular trap formation.

Authors:  Abdul Hakkim; Tobias A Fuchs; Nancy E Martinez; Simone Hess; Heino Prinz; Arturo Zychlinsky; Herbert Waldmann
Journal:  Nat Chem Biol       Date:  2010-12-19       Impact factor: 15.040

2.  Platelet-activating factor stimulates receptor-mediated formation of reactive oxygen intermediates in human monocytes.

Authors:  M G Pustynnikov; N V Porodenko; O V Makarova; A V Kozyukov; A A Sokolovsky; E S Severin
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

3.  Role of platelet-activating factor (PAF) in superoxide production by human polymorphonuclear leukocytes.

Authors:  S Takahashi; T Yoshikawa; Y Naito; T Tanigawa; N Yoshida; M Kondo
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

4.  Accumulation of phosphatidic acid mass and increased de novo synthesis of glycerolipids in platelet-activating-factor-activated human neutrophils.

Authors:  J Tou; J R Jeter; C P Dola; S Venkatesh
Journal:  Biochem J       Date:  1991-12-15       Impact factor: 3.857

Review 5.  The role of the microcirculation in multiple organ dysfunction syndrome (MODS): a review and perspective.

Authors:  C J Kirkpatrick; F Bittinger; C L Klein; S Hauptmann; B Klosterhalfen
Journal:  Virchows Arch       Date:  1996-02       Impact factor: 4.064

Review 6.  Polymorphonuclear leucocyte traffic in lung inflammation.

Authors:  J C Hogg; B A Walker
Journal:  Thorax       Date:  1995-08       Impact factor: 9.139

7.  TCV-309, a novel platelet activating factor antagonist, inhibits leukocyte accumulation and protects against splanchnic artery occlusion shock.

Authors:  P Canale; F Squadrito; D Altavilla; M Ioculano; B Zingarelli; G M Campo; G Urna; A Sardella; G Squadrito; A P Caputi
Journal:  Agents Actions       Date:  1994-10

8.  Involvement of leukotriene B4 and platelet-activating factor in cytokine priming of human polymorphonuclear leucocytes.

Authors:  A G Stewart; T Harris; M De Nichilo; A F Lopez
Journal:  Immunology       Date:  1991-02       Impact factor: 7.397

9.  Regulation of platelet-activating-factor receptors and the desensitization response in polymorphonuclear neutrophils.

Authors:  J T O'Flaherty; D P Jacobson; J F Redman
Journal:  Biochem J       Date:  1992-11-15       Impact factor: 3.857

10.  Direct and indirect effects of E. coli lipopolysaccharide on isolated human polymorphonuclear granulocytes and mixed leukocytes.

Authors:  H Opdahl
Journal:  Inflammation       Date:  1993-02       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.